FDA to probe ADHD drug safety
FDA Review ADHD Drug Safety. The US Food and Drug Administration is planning to review the cardiovascular risks of attention-deficit hyperactivity disorder treatments, and has asked an advisory panel to discuss the issue at a meeting on February 9-10. The move follows reports of sudden deaths, strokes, heart attacks and high blood … [Read more...] about FDA to probe ADHD drug safety
European Drug Agency Backs Heart Warning
European Drug Agency Heart Warning. The European Medicines Agency said Thursday it would require stronger warnings about the cardiovascular risks associated with the Cox-2 class of arthritis painkillers. It stopped short of calling for the drugs, which are also being scrutinized by the Food and Drug Administration, to be … [Read more...] about European Drug Agency Backs Heart Warning
